اثربخشی برنامه چندوجهی مدیریت استرس LEARN در کاهش استرس ادراک شده و بهبود علائم سندروم روده تحریک‌‌پذیر

نویسندگان
احمد علی پور
مهناز علی اکبری دهکردی
الهام موسوی
دانشگاه پیام نور
10.52547/rph.14.4.104
چکیده
این مطالعه یک گزارش موردی است که با هدف بررسی اثربخشی برنامه چندوجهی مدیریت استرس LEARN در کاهش استرس ادراک شده و بهبود علائم سندروم روده تحریک‌‌پذیر (IBS) انجام شد. نمونه این مطالعه شامل دو نفر زن مبتلا به IBS شدید بود که به صورت نمونه‌‌گیری در دسترس از میان مراجعه‌‌کنندگان به مطب پزشک فوق تخصص گوارش در منطقه ظفر شهر تهران بر اساس معیارهای ورود- خروج انتخاب شدند. استرس ادراک شده و شدت علائم IBS قبل از مداخله، حین اجرا و سه ماه بعد از پایان جلسات به ترتیب با استفاده از مقیاس استرس ادراک شده (PSS) و مقیاس GISR مورد بررسی قرار گرفت. تحلیل نتایج با استفاده از رسم نمودار و محاسبه شاخص بهبودی با استفاده از فرمول گفته شده که بیانگر اثربخشی برنامه LEARN در کاهش استرس ادراک شده و شدت علائم گوارشی IBS بود. همچنین این بهبودی در پیگیری سه ماهه پس از مداخله در دامنه‌‌ای از 50 تا 56 درصد حفظ شد. بنابراین براساس مدل زیستی- روانی- اجتماعی برنامه چند وجهی LEARN به واسطه مؤلفه‌‌های اثرگذار می‌‌تواند گزینه درمانی مناسبی برای بیماران مبتلا به IBS محسوب شود.
کلیدواژه‌ها
برنامه LEARN
استرس ادراک شده
سندروم روده تحریک‌‌پذیر

عنوان مقاله English

Effectiveness of LEARN Multifaceted Stress Management Program in Reducing Perceived Stress and Improving Irritable Bowel Syndrome (IBS) Symptoms

نویسندگان English

Ahmad Alipour
Mahnaz Ali Akbari Dehkordi
Elhan Mousavi
Payame noor university
چکیده English

This study is a case report that aimed to evaluate the effectiveness of LEARN multifaceted stress management program in reducing perceived stress and improving irritable bowel syndrome (IBS) symptoms. The research samples, were two women with severe IBS, selected from the ones seeing a gastroenterology subspecialist in Zafar area of Tehran, via convenience sampling method and based on inclusion-exclusion criteria. Perceived stress and severity of IBS symptoms were measured by Perceived Stress Scale (PSS) and GISR scale respectively, before intervention, during implementation and three months after the end of sessions. Findings’ analysis using graph drawing and remission index calculation with that formula, represented the effectiveness of LEARN multifaceted stress management program in perceived stress reduction and IBS symptoms improvement. Also, this improvement was maintained in the range of 50% to 56%, in three-month follow-up after the intervention. Therefore, based on biopsychosocial model, due to effective components of LEARN multifaceted program, this program can be considered as a suitable treatment option for IBS.


کلیدواژه‌ها English

LEARN program
perceived stress
Irritable bowel syndrome
Laird KT, Tanner-Smith EE, Russell AC, Hollon SD, & Walker LS. Comparative efficacy of psychological therapies for improving mental health and daily functioning in irritable bowel syndrome: A systematic review and meta-analysis. Clinical Psychology Review. 2017; 51:142-152.
Basnayake C. Treatment of irritable bowel syndrome. Ustralian prescriber. 2018; 41(5):145-149.
Lee TY, Hsieh TC, Sung HC, Chen WL. Internet-Delivered Cognitive Behavior Therapy for Young Taiwanese Female Nursing Students with Irritable Bowel Syndrome—A Cluster Randomized Controlled Trial. International journal of environmental research and public health. 2019; 16(5): 708.
Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006; 130(5): 1377-1390.
Van Oudenhove L, Levy RL, Crowell MD, Drossman DA, Halpert AD, Keefer L, Naliboff BD. Biopsychosocial aspects of functional gastrointestinal disorders: how central and environmental processes contribute to the development and expression of functional gastrointestinal disorders. Gastroenterology. 2016; 150(6): 1355-1367.
Van Tilburg MA, Palsson OS, Whitehead WE. Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model. Journal of psychosomatic research. 213; 74(6): 486-492.
Wilkins T, Pepitone C, Alex B, & Schade RR. Diagnosis and management of IBS in adults. American family physician. 2012; 86(5): 419-26.
Chang FY, Lu CL. The clinical significances of irritable bowel syndrome in Taiwan. Journal of gastroenterology and hepatology. 2011; 26: 102-105.
Drossman D A, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Richter JE. US householder survey of functional gastrointestinal disorders. Digestive diseases and sciences. 1993; 38(9): 1569-1580.
Heitkemper MM, Jarrett ME, Levy RL, Cain KC, Burr RL, Feld A, Weisman P. Self-management for women with irritable bowel syndrome. Clinical Gastroenterology and Hepatology. 2004; 2(7): 585-596.
Lovell RM, & Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clinical gastroenterology and hepatology. 2012; 10(7): 712-721.
Ford AC, Lacy BE, Talley NJ. Irritable Bowel Syndrome. N Engl J Med Overseas Ed. 2017; 376: 2566–78.
Canavan C, West J, & Card T. The epidemiology of irritable bowel syndrome. Clinical epidemiology. 2014; 4(6): 71-80.
Buono JL, Mathur K, Averitt AJ, & Andrae DA. Economic burden of irritable bowel syndrome with diarrhea: retrospective analysis of a US commercially insured population. Journal of managed care & specialty pharmacy. 2017; 23(4): 453-460.
Hulisz D. The burden of illness of irritable bowel syndrome: current challenges and hope for the future. Journal of managed care pharmacy. 2004; 10(4): 299-309.
Smith GD, Steinke DT, Kinnear M, Penny KI, Pathmanathan N, & Penman ID (2004). A comparison of irritable bowel syndrome patients managed in primary and secondary care: the Episode IBS study. Br J Gen Pract. 2004; 54(504): 503-507.
Tillisch K. Complementary and alternative medicine for gastrointestinal disorders. Clinical medicine. 2007; 7(3): 224-227.
Jin S, Li YF, Qin D, Luo DQ, Guo H, Gao XH, & Zheng, H. Non-pharmacological treatments for irritable bowel syndrome: study protocol of an umbrella review of systematic review and meta-analyses. BMJ open. 2019; 9(3): e027778.
Malone M, Allen S, Katz J, McCauley M, & Watson H. Irritable Bowel Syndrome: A Review and Update. SL Gastroenterology. 2018; 1(2):118-126.
Johannesson E, Simrén M, Strid H, Bajor A, & Sadik R. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. The American journal of gastroenterology. 2011; 106(5): 915-22.
Saito YA, Locke GR, Weaver AL, Zinsmeister AR, Talley NJ. Diet and Functional Gastrointestinal Disorders: A Population-Based Case—Control Study. The American journal of gastroenterology. 2005; 100(12): 2743-8.
Siah KTH, Wong RKM, & Ho KY. Melatonin for the treatment of irritable bowel syndrome. World journal of gastroenterology. 2014; 20(10): 2492-2498.
Ford AC, Harris LA, Lacy BE, Quigley EM, & Moayyedi P. Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Alimentary pharmacology & therapeutics. 2018; 48(10): 1044-1060.
Grundmann O, Yoon SL. Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health‐care practitioners. Journal of gastroenterology and hepatology. 2010; 25(4): 691-699.
Eswaran SL, Chey WD, Han-Markey T, Ball S, Jackson K. A randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D. The American journal of gastroenterology. 2016; 111(12): 1824-1832.
Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer. 1984.
Edman JS, Greeson JM, Roberts RS, Kaufman AB, Abrams DI, Dolor RJ, & Wolever RQ. Perceived Stress in Patients with Common Gastrointestinal Disorders: Associations with Quality of Life, Symptoms and Disease Management. Explore (New York, N.Y.). 2017; 13(2): 124–128.
Racic M, Todorovic R, Ivkovic N, Masic S, Joksimovic B, & Kulic M. Self- Perceived Stress in Relation to Anxiety, Depression and Health-related
Quality of Life among Health Professions Students: A Cross-sectional Study from Bosnia and Herzegovina. Zdravstveno varstvo. 2017; 56(4): 251–259.
Kearney DJ, & Brown-Chang J. Complementary and alternative medicine for IBS in adults: mind–body interventions. Nature Reviews Gastroenterology & Hepatology. 2008; 5(11): 624-36.
Radu M, Moldovan R, Pintea S, Băban A, Dumitrașcu D. Predictors of outcome in cognitive and behavioural interventions for irritable bowel syndrome. A meta-analysis. Journal of Gastrointestinal & Liver Diseases. 2018; 27(3): 257-263.
Lackner JM, Jaccard J, Keefer L, Brenner DM, Firth RS, Gudleski GD, Radziwon CD. Improvement in gastrointestinal symptoms after cognitive behavior therapy for refractory irritable bowel syndrome. Gastroenterology. 2018; 155(1): 47-57.
Barlow DH, Rapee RM, Reisner LC. Mastering Stress. Euless: American Health Publishing Company. 2001.
Cohen S, Kamarck T, Mermelstein RA. Global measure of perceived stress. Journal of Health and Social Behavior. 1983; 24:385-96.
Dai N, Cong Y, Yuan H. Prevalence of irritable bowel syndrome among undergraduates in Southeast China. Dig Liver Dis. 2008; 40(6): 418- 24.
Hunt MG, Ertel E, Coello JA, & Rodriguez L. Empirical support for a self-help treatment for IBS. Cognitive Therapy and Research. 2015; 39(2): 215-227.
Ballou S, Keefer L. The impact of irritable bowel syndrome on daily functioning: Characterizing and understanding daily consequences of IBS. Neurogastroenterology & Motility. 2017; 29(4): e12982.